(Q38349738)

2 September 2017

1 reference

title

Type 1 reaction in leprosy: a model for a better understanding of tissue immunity under an immunopathological condition (English)

1 reference

2 September 2017

0 references

Ximena Illarramendi

4

0 references

Milton Ozorio Moraes

object named as

Milton Ozório Moraes

6

0 references

Euzenir Nunes Sarno

object named as

Euzenir Nunes Sarno

10

0 references

author name string

Priscila Ribeiro Andrade

1

1 reference

2 September 2017

Roberta Olmo Pinheiro

2

1 reference

2 September 2017

Anna Maria Sales

3

1 reference

2 September 2017

Mayara Garcia de Mattos Barbosa

5

1 reference

2 September 2017

Marcia Rodrigues Jardim

7

1 reference

2 September 2017

Jose Augusto da Costa Nery

8

1 reference

2 September 2017

Elizabeth Pereira Sampaio

9

1 reference

2 September 2017

publication date

10 February 2015

1 reference

Expert Review of Clinical Immunology

2 September 2017

published in

1 reference

2 September 2017

volume

11

1 reference

2 September 2017

issue

3

1 reference

2 September 2017

page(s)

391-407

1 reference

Understanding the type 1 reactional state for early diagnosis and treatment: a way to avoid disability in leprosy

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012501

Genetics of leprosy reactions: an overview.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012501

Diagnosis and treatment of leprosy reactions in integrated services--the patients' perspective in Nepal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012501

Hansen's disease (Leprosy): current and future pharmacotherapy and treatment of disease-related immunologic reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012501

Predicting neuropathy and reactions in leprosy at diagnosis and before incident events-results from the INFIR cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012501

Leprosy reactions: coinfections as a possible risk factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012501

The recurrence of leprosy reactional episodes could be associated with oral chronic infections and expression of serum IL-1, TNF-alpha, IL-6, IFN-gamma and IL-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012501

Epidemiological and clinical patterns of 92 patients co-infected with HIV and Mycobacterium leprae from Rio de Janeiro State, Brazil.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012501

Interactions between HIV infection and leprosy: a paradox

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012501

Leprosy reversal reaction as immune reconstitution inflammatory syndrome in patients with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012501

The histological diagnosis of leprosy type 1 reactions: identification of key variables and an analysis of the process of histological diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012501

Analysis of naturally occurring delayed-type hypersensitivity reactions in leprosy by in situ hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012501

Selective expansion of V delta 1 + T cells from leprosy skin lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012501

Sequential erythema nodosum leprosum and reversal reaction with similar lesional cytokine mRNA patterns in a borderline leprosy patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012501

TLR6-driven lipid droplets in Mycobacterium leprae-infected Schwann cells: immunoinflammatory platforms associated with bacterial persistence

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012501

Modulation of lipid droplets by Mycobacterium leprae in Schwann cells: a putative mechanism for host lipid acquisition and bacterial survival in phagosomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012501

Tumor necrosis factor blockade in chronic murine tuberculosis enhances granulomatous inflammation and disorganizes granulomas in the lungs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012501

Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012501

Mitochondria released by cells undergoing TNF-α-induced necroptosis act as danger signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012501

Cytokine and protein markers of leprosy reactions in skin and nerves: baseline results for the North Indian INFIR cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012501

Activation and regulation of Toll-like receptors 2 and 1 in human leprosy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012501

Increased CXC ligand 10 levels and gene expression in type 1 leprosy reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012501

Potential plasma markers of Type 1 and Type 2 leprosy reactions: a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012501

Vitamin D is required for IFN-gamma-mediated antimicrobial activity of human macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012501

Vitamin D and the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012501

Divergence of macrophage phagocytic and antimicrobial programs in leprosy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012501

Role of indoleamine 2,3-dioxygenase in antimicrobial defence and immuno-regulation: tryptophan depletion versus production of toxic kynurenines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012501

Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012501

The role of indoleamine 2, 3-dioxygenase in lepromatous leprosy immunosuppression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012501

CD163 favors Mycobacterium leprae survival and persistence by promoting anti-inflammatory pathways in lepromatous macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012501

The role of IFN-gamma and TNF-alpha-responsive regulatory elements in the synergistic induction of indoleamine dioxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012501

SOCS3 drives proteasomal degradation of indoleamine 2,3-dioxygenase (IDO) and antagonizes IDO-dependent tolerogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012501

Proteasomal Degradation of Indoleamine 2,3-Dioxygenase in CD8 Dendritic Cells is Mediated by Suppressor of Cytokine Signaling 3 (SOCS3)

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012501

Type I interferon suppresses type II interferon-triggered human anti-mycobacterial responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012501

Inflammation and metabolic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012501

Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012501

Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012501

Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012501

Protective and pathogenic functions of macrophage subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012501

Exploring the full spectrum of macrophage activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012501

Macrophage plasticity and polarization: in vivo veritas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012501

Macrophage activation and polarization: nomenclature and experimental guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012501

Contact-dependent demyelination by Mycobacterium leprae in the absence of immune cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012501

Reprogramming adult Schwann cells to stem cell-like cells by leprosy bacilli promotes dissemination of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012501

Innate immune response precedes Mycobacterium leprae-induced reprogramming of adult Schwann cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012501

Cytokines and Mycobacterium leprae induce apoptosis in human Schwann cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012501

Mycobacterium leprae-specific, HLA class II-restricted killing of human Schwann cells by CD4+ Th1 cells: a novel immunopathogenic mechanism of nerve damage in leprosy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012501

Schwann cells producing matrix metalloproteinases under Mycobacterium leprae stimulation may play a role in the outcome of leprous neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012501

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012501

Emerging concepts on inhibitors of indoleamine 2,3-dioxygenase in rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012501

Toll-like receptor 2 (TLR2) polymorphisms are associated with reversal reaction in leprosy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012501

Human TLR1 deficiency is associated with impaired mycobacterial signaling and protection from leprosy reversal reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012501

Polymorphism N248S in the human Toll-like receptor 1 gene is related to leprosy and leprosy reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012501

Common polymorphisms in the NOD2 gene region are associated with leprosy and its reactive states

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012501

Genetic and immunological evidence implicates interleukin 6 as a susceptibility gene for leprosy type 2 reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012501

Interleukin-17F single-nucleotide polymorphism (7488T>C) and its association with susceptibility to leprosy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012501

A randomized clinical trial of oral steroids for ulnar neuropathy in type 1 and type 2 leprosy reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012501

Current perspectives on interferon Beta-1b for the treatment of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012501

Multiple sclerosis: current knowledge and future outlook

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012501

Type I IFN induces IL-10 production in an IL-27-independent manner and blocks responsiveness to IFN-γ for production of IL-12 and bacterial killing in Mycobacterium tuberculosis-infected macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012501

Inflammasome and cytokine blocking strategies in autoinflammatory disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012501

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012501

Tacrolimus ointment causes inflammatory dendritic epidermal cell depletion but no Langerhans cell apoptosis in patients with atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012501

Calcineurin inhibitors suppress cytokine production from memory T cells and differentiation of naïve T cells into cytokine-producing mature T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012501

Innovative use of topical calcineurin inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012501

Type 1 leprosy reversal reaction treated with topical tacrolimus along with systemic corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012501

Severe refractory erythema nodosum leprosum successfully treated with the tumor necrosis factor inhibitor etanercept

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012501

Peroxisome proliferator-activated receptors in cutaneous biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012501

Effect of topical PPARbeta/delta and PPARgamma agonists on plaque psoriasis. A pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012501

Peroxisome proliferator-activated receptor agonists (PPARs): a promising prospect in the treatment of psoriasis and psoriatic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012501

Troglitazone improves psoriasis and normalizes models of proliferative skin disease: ligands for peroxisome proliferator-activated receptor-gamma inhibit keratinocyte proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012501

High matrix metalloproteinase production correlates with immune activation and leukocyte migration in leprosy reactional lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012501

A chemical biological strategy to facilitate diabetic wound healing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012501

Matrix metalloproteinases and their role in psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012501

Longitudinal immune responses and gene expression profiles in type 1 leprosy reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012501

The skin-resident and migratory immune system in steady state and memory: innate lymphocytes, dendritic cells and T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012501

Clinical outcomes in a randomized controlled study comparing azathioprine and prednisolone versus prednisolone alone in the treatment of severe leprosy type 1 reactions in Nepal

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012501

Response to ciclosporin treatment in Ethiopian and Nepali patients with severe leprosy Type 1 reactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012501

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012501

Type I Interferon Inhibits Interleukin-1 Production and Inflammasome Activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012501

10.1586/1744666X.2015.1012501

21 January 2018

Identifiers

DOI

1 reference

2 September 2017

1 reference